Chimovits Erez
CIK: 0001706399
Director
Primary company: LogicBio Therapeutics, Inc. (LOGC)
Chimovits Erez is a corporate insider at LogicBio Therapeutics, Inc. (LOGC) filing SEC Form 4 transactions. 40 transactions across 5 companies, totaling $30,016,303 in purchases and $258,482 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 256,448 | - | - | 0 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 513,067 | - | - | 0 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 1,333,975 | - | - | 0 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 7,127,019 | - | - | 0 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Purchase | 61,516 | $17.00 | $1.05M | 9,292,025 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 256,448 | - | - | 9,230,509 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 513,067 | - | - | 8,974,061 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 1,333,975 | - | - | 8,460,994 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 7,127,019 | - | - | 7,127,019 | 9/28/2026 Filed: 9/28/2026 | Filing → |
Braveheart Bio, Inc. BRVE | Conversion | 9,132,420 | - | - | 0 | 8/7/2026 Filed: 8/7/2026 | Filing → |
Braveheart Bio, Inc. BRVE | Purchase | 273,333 | $18.00 | $4.92M | 273,333 | 8/7/2026 Filed: 8/7/2026 | Filing → |
Braveheart Bio, Inc. BRVE | Purchase | 1,666,667 | $18.00 | $30.00M | 11,901,826 | 8/7/2026 Filed: 8/7/2026 | Filing → |
Braveheart Bio, Inc. BRVE | Conversion | 9,132,420 | - | - | 10,235,159 | 8/7/2026 Filed: 8/7/2026 | Filing → |
Braveheart Bio, Inc. BRVE | Award | 30,000 | $18.00 | $540K | 30,000 | 8/5/2026 Filed: 8/5/2026 | Filing → |
| Award | 17,096 | $6.69 | $114K | 17,096 | 6/9/2026 Filed: 6/9/2026 | Filing → | |
| Award | 17,096 | - | - | 17,096 | 6/10/2025 Filed: 6/12/2025 | Filing → | |
| Conversion | 789,833 | - | - | 0 | 10/15/2024 Filed: 10/17/2024 | Filing → | |
| Conversion | 197,456 | - | - | 0 | 10/15/2024 Filed: 10/17/2024 | Filing → | |
| Conversion | 2,098,000 | - | - | 0 | 10/15/2024 Filed: 10/17/2024 | Filing → | |
| Conversion | 524,500 | - | - | 0 | 10/15/2024 Filed: 10/17/2024 | Filing → |
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
256,448
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
513,067
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
1,333,975
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
7,127,019
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Purchase
Shares
61,516
Price
$17.00
Value
$1.05M
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
256,448
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
513,067
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
1,333,975
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
7,127,019
Price
-
Value
-
Braveheart Bio, Inc.
BRVE
Type
Conversion
Shares
9,132,420
Price
-
Value
-
Braveheart Bio, Inc.
BRVE
Type
Purchase
Shares
273,333
Price
$18.00
Value
$4.92M
Braveheart Bio, Inc.
BRVE
Type
Purchase
Shares
1,666,667
Price
$18.00
Value
$30.00M
Braveheart Bio, Inc.
BRVE
Type
Conversion
Shares
9,132,420
Price
-
Value
-
Braveheart Bio, Inc.
BRVE
Type
Award
Shares
30,000
Price
$18.00
Value
$540K
Type
Award
Shares
17,096
Price
$6.69
Value
$114K
Type
Award
Shares
17,096
Price
-
Value
-
Type
Conversion
Shares
789,833
Price
-
Value
-
Type
Conversion
Shares
197,456
Price
-
Value
-
Type
Conversion
Shares
2,098,000
Price
-
Value
-
Type
Conversion
Shares
524,500
Price
-
Value
-
AI Agent
Try asking...